Global Generic Injectables Market Research, Size, Witness Stunning Growth By 2028 | The Insight Partners - PowerPoint PPT Presentation

About This Presentation
Title:

Global Generic Injectables Market Research, Size, Witness Stunning Growth By 2028 | The Insight Partners

Description:

According to our new research study on Generic Injectables Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by product type, container type, application, and route of administration,” the generic injectables market size is expected to grow from US$ 74.74 billion in 2021 to US$ 150.65 billion by 2028; it is estimated to grow at a CAGR of 10.5% during 2021–2028. The generic injectables market growth is attributed to low R&D, marketing, and manufacturing costs, and the rising prevalence of chronic illness cases are expected to drive the growth of the market. – PowerPoint PPT presentation

Number of Views:0
Slides: 9
Provided by: nikhilghodse94@gmail
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Global Generic Injectables Market Research, Size, Witness Stunning Growth By 2028 | The Insight Partners


1
Generic Injectables Market Global Analysis and
Forecast to 2028
  • Published Date Mar 2022

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com
  • Generic Injectables Market Forecast to 2028 -
    COVID-19 Impact and Global Analysis By Product
    Type (Large Molecule Injectables and Small
    Molecule Injectables), Container Type (Vials,
    Premix, Prefilled Syringes, Ampoules, and
    Others), Application (Oncology, Infectious
    Diseases, Cardiology, Diabetes, Immunology, and
    Others), and Route of Administration
    (Intravenous, Intramuscular, Subcutaneous, and
    Others), and Geography

3
Generic Injectables Market Overview
Email sales_at_theinsightpartners.com
  • The generic injectables market is projected to
    reach US 150.65 billion by 2028 from US 74.74
    billion in 2021 it is expected to register a
    CAGR of 10.5 from 2021 to 2028.
  • Generic injectables are the bioequivalents of
    their branded counterparts and are not protected
    by patents. They are safe and effective as the
    innovator drugs since they have similar active
    ingredients, dosages, strength, qualities, form,
    etc.

4
Key Segment Market
Email sales_at_theinsightpartners.com
  • Segment By Type-
  • By Product Type (Large Molecule Injectables and
    Small Molecule Injectables)
  • Application (Oncology, Infectious Diseases,
    Cardiology, Diabetes, Immunology, and Others)
  • Container Type (Vials, Premix, Prefilled
    Syringes, Ampoules, and Others)

Download Sample Here
5
Generic Injectables Market Value
Email sales_at_theinsightpartners.com
  • CAGR of 10.5
  • (2021 - 2028)

Download Sample
6
Company Profiles
Email sales_at_theinsightpartners.com
  • Astrazeneca
  • Baxter International, Inc.
  • Biocon
  • Fresenius SE Co. KGaA
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals
  • Johnson Johnson Services, Inc.
  • Lupin, Ltd.
  • Merck Co., Inc.
  • Mylan N.V.
  • Pfizer, Inc

Download Sample Here
7
By Geography
Email sales_at_theinsightpartners.com
  • North America (the US, Canada, and Mexico)
  • Europe (the UK, Germany, France, Italy, Spain,
    and the Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia,
    South Korea, and the Rest of Asia Pacific)
  • Middle East Africa (the UAE, Saudi Arabia,
    South Africa, and the Rest of Middle East
    Africa)
  • South Central America (Brazil, Argentina, and
    the Rest of South Central America).

8
THANKYOU!
  • Phone  1-646-491-9876
  • E-Mail sales_at_theinsightpartners.com
Write a Comment
User Comments (0)
About PowerShow.com